HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johannes H A M Kaanders Selected Research

CCI 103F

2/2007Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers.
3/2006Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model.
7/2005Hypoxic cell turnover in different solid tumor lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Johannes H A M Kaanders Research Topics

Disease

67Neoplasms (Cancer)
11/2021 - 03/2002
44Hypoxia (Hypoxemia)
01/2015 - 03/2002
39Head and Neck Neoplasms (Head and Neck Cancer)
12/2022 - 12/2002
33Squamous Cell Carcinoma of Head and Neck
01/2022 - 09/2002
14Carcinoma (Carcinomatosis)
01/2019 - 06/2002
11Prostatic Neoplasms (Prostate Cancer)
07/2013 - 06/2006
10Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2021 - 04/2003
10Neoplasm Metastasis (Metastasis)
01/2018 - 10/2005
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2019 - 06/2008
5Laryngeal Neoplasms (Laryngeal Cancer)
04/2020 - 01/2007
3Deglutition Disorders (Dysphagia)
01/2022 - 01/2014
3Lymphatic Metastasis
06/2020 - 03/2012
3Adenocarcinoma
12/2019 - 06/2012
2Xerostomia
01/2022 - 01/2017
2Pain (Aches)
01/2022 - 04/2018
2Glioma (Gliomas)
01/2019 - 03/2009
2Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
01/2016 - 11/2010
2Weight Loss (Weight Reduction)
01/2014 - 09/2010
2Malnutrition (Nutritional Deficiencies)
01/2014 - 09/2010
2Melanoma (Melanoma, Malignant)
02/2008 - 07/2006
2Colorectal Neoplasms (Colorectal Cancer)
02/2006 - 10/2005
2Nausea
06/2002 - 03/2002
2Vomiting
06/2002 - 03/2002
1Osteoradionecrosis
01/2022
1Trismus (Lockjaw)
01/2022
1Ulcer
11/2021
1Astrocytoma (Pilocytic Astrocytoma)
05/2021
1Hemangiopericytoma
01/2020
1Mucositis
01/2020
1Solitary Fibrous Tumors
01/2020
1Ototoxicity
01/2019
1Paraganglioma (Paragangliomas)
12/2018
1Residual Neoplasm
12/2018
1Hypothyroidism
01/2017
1AIDS-Related Complex (ARC)
01/2017

Drug/Important Bio-Agent (IBA)

21pimonidazoleIBA
09/2014 - 09/2002
14ErbB Receptors (EGF Receptor)IBA
01/2016 - 04/2009
12Proteins (Proteins, Gene)FDA Link
12/2019 - 06/2006
11Carbonic Anhydrase IXIBA
10/2014 - 12/2002
10Biological ProductsIBA
10/2014 - 01/2005
9carbogenIBA
10/2013 - 03/2002
9Niacinamide (Nicotinamide)FDA LinkGeneric
10/2013 - 03/2002
8Oxygen (Dioxygen)IBA
01/2022 - 09/2002
8Glucose (Dextrose)FDA LinkGeneric
12/2019 - 10/2005
8Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2017 - 10/2005
8Cetuximab (Erbitux)FDA Link
01/2016 - 08/2011
6Biomarkers (Surrogate Marker)IBA
08/2015 - 06/2005
6Idoxuridine (Stoxil)FDA LinkGeneric
05/2010 - 01/2005
5Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
12/2019 - 02/2006
5Messenger RNA (mRNA)IBA
12/2019 - 10/2013
5fluoromisonidazoleIBA
10/2013 - 08/2006
4Cisplatin (Platino)FDA LinkGeneric
01/2019 - 11/2011
4alovudineIBA
04/2013 - 05/2007
3Phosphotransferases (Kinase)IBA
06/2015 - 06/2009
3Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
09/2014 - 03/2008
3Crystallins (Crystallin)IBA
04/2014 - 03/2013
3bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
07/2010 - 09/2002
3CCI 103FIBA
02/2007 - 07/2005
2Fluorouracil (Carac)FDA LinkGeneric
01/2019 - 04/2018
2Docetaxel (Taxotere)FDA Link
01/2019 - 04/2018
2Monoclonal AntibodiesIBA
08/2015 - 07/2010
2Radioisotopes (Radionuclides)IBA
08/2015 - 07/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2014 - 11/2013
2VimentinIBA
10/2013 - 06/2011
2Cadherins (E-Cadherin)IBA
10/2013 - 06/2011
2Epidermal Growth Factor (EGF)IBA
09/2013 - 01/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2013 - 01/2007
2Hemoglobins (Hemoglobin)IBA
12/2010 - 01/2006
2NitroimidazolesIBA
07/2010 - 12/2002
2ParaffinIBA
05/2010 - 02/2006
2Erythropoietin Receptors (Erythropoietin Receptor)IBA
06/2007 - 08/2005
2Gadolinium DTPA (Magnevist)FDA Link
10/2005 - 07/2004
2GadoliniumIBA
07/2004 - 08/2002
1ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA
12/2022
1Glucose Transporter Type 1IBA
12/2019
1Glutamine (L-Glutamine)FDA Link
12/2019
1GlutaminaseIBA
12/2019
1Protons (Proton)IBA
12/2016

Therapy/Procedure

88Radiotherapy
01/2022 - 03/2002
24Therapeutics
03/2021 - 06/2002
11Aftercare (After-Treatment)
04/2020 - 09/2004
7Chemoradiotherapy
01/2022 - 04/2013
6Drug Therapy (Chemotherapy)
08/2015 - 06/2009
3Brachytherapy
11/2021 - 11/2010
3Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
05/2021 - 10/2009
3Prostatectomy (Retropubic Prostatectomy)
03/2012 - 12/2010
2Neck Dissection (Radical Neck Dissection)
12/2022 - 12/2013
2Proton Therapy
05/2021 - 01/2019
2Time-to-Treatment
04/2020 - 01/2020
2Induction Chemotherapy
01/2019 - 04/2018
2Re-Irradiation
01/2017 - 12/2016
2Metastasectomy
02/2006 - 10/2005
1Enteral Nutrition (Feeding, Tube)
01/2022
1Activities of Daily Living (ADL)
01/2022
1Immunotherapy
03/2021
1Palliative Care (Palliative Therapy)
01/2020
1Combined Modality Therapy
01/2019
1Salvage Therapy
01/2019
1Drug Tapering
01/2017
1Heavy Ion Radiotherapy
12/2016